Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look.

Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ.

BMJ Evid Based Med. 2019 Jun;24(3):99-102. doi: 10.1136/bmjebm-2018-111110. Epub 2018 Dec 10. No abstract available.

PMID:
30530806
2.

Unbalanced risk-benefit analysis of ADHD drugs.

Faltinsen EG, Gluud C, Simonsen E, Zwi M, Storebø OJ.

Lancet Psychiatry. 2018 Nov;5(11):870. doi: 10.1016/S2215-0366(18)30334-1. Epub 2018 Oct 26. No abstract available.

PMID:
30401440
3.

The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Storebø OJ, Faltinsen E, Zwi M, Simonsen E, Gluud C.

Clin Pharmacol Ther. 2018 Oct;104(4):606-609. doi: 10.1002/cpt.1149. Epub 2018 Jul 13.

PMID:
30006934
4.

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2018 May 9;5:CD012069. doi: 10.1002/14651858.CD012069.pub2. Review.

5.

Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.

Holmskov M, Storebø OJ, Moreira-Maia CR, Ramstad E, Magnusson FL, Krogh HB, Groth C, Gillies D, Zwi M, Skoog M, Gluud C, Simonsen E.

PLoS One. 2017 Jun 15;12(6):e0178187. doi: 10.1371/journal.pone.0178187. eCollection 2017. Review.

6.

Evidence on methylphenidate in children and adolescents with ADHD is in fact of 'very low quality'.

Storebø OJ, Zwi M, Krogh HB, Moreira-Maia CR, Holmskov M, Gillies D, Groth C, Simonsen E, Gluud C.

Evid Based Ment Health. 2016 Nov;19(4):100-102. doi: 10.1136/eb-2016-102499. Epub 2016 Oct 8.

PMID:
27935808
7.

Response to "Trust, but verify" by Banaschewski et al.

Storebø OJ, Zwi M, Moreira-Maia CR, Skoog M, Camilla G, Gillies D, Simonsen E, Gluud C.

Z Kinder Jugendpsychiatr Psychother. 2016 Sep;44(5):334-335. No abstract available.

8.

Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

BMJ. 2015 Nov 25;351:h5203. doi: 10.1136/bmj.h5203. Review.

9.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

PMID:
26599576
10.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

11.

Parent training interventions for attention deficit hyperactivity disorder.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2009;(3). pii: CD003018.

12.

Injury and attention deficit hyperactivity disorder.

Zwi M, Clamp P.

BMJ. 2008 Nov 6;337:a2244. doi: 10.1136/bmj.a2244. No abstract available.

PMID:
18988645
13.

Attention deficit hyperactivity disorder.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2003 Jun;(9):318-27. Review. No abstract available. Update in: Clin Evid. 2005 Jun;(13):266-79.

PMID:
12967364
14.

Attention-deficit/hyperactivity disorder.

Joughin C, Ramchandani P, Zwi M.

Am Fam Physician. 2003 May 1;67(9):1969-70. No abstract available.

15.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Dec;(8):280-90. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):318-27.

PMID:
12603883
16.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Jun;(7):262-71. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):280-90.

PMID:
12230649
17.

Evidence and belief in ADHD.

Zwi M, Ramchandani P, Joughin C.

BMJ. 2000 Oct 21;321(7267):975-6. No abstract available.

18.

Isolation and use of chromosome 1 probes for linkage studies on Charcot-Marie-Tooth disease.

Griffiths LR, Zwi MB, Mesterovic N, Ross DA, Board PG, Callen DF, Mohandas T, Buckland R, Fletcher JM, Driesel AJ.

Ann Hum Genet. 1990 Jan;54(1):31-7.

PMID:
2321912
19.

Heterogeneity evidence and linkage studies on Charcot-Marie-Tooth disease.

Griffiths LR, Zwi MB, McLeod JG, Ross DA, Nicholson GA.

Neurology. 1989 Feb;39(2 Pt 1):280-1.

PMID:
2915802
20.

The B subunit of coagulation factor XIII is linked to renin and the Duffy blood group to alpha-spectrin on human chromosome 1.

Griffiths LR, Board PG, Zwi MB, Morris BJ, McLeod JG, Nicholson GA.

Hum Hered. 1989;39(2):107-9.

PMID:
2668157
21.

Chromosome I linkage studies in Charcot-Marie-Tooth neuropathy type I.

Griffiths LR, Zwi MB, McLeod JG, Nicholson GA.

Am J Hum Genet. 1988 May;42(5):756-71.

22.

Regional chromosomal assignment of human renin gene to 1q12----qter and use in linkage studies in Charcot-Marie-Tooth disease.

Griffiths LR, Nicholson GA, Ross DA, Zwi MB, McLeod JG, Mohandas T, Morris BJ.

Cytogenet Cell Genet. 1987;45(3-4):231-3.

PMID:
3319438

Supplemental Content

Support Center